Salivary duct carcinoma: Prospective multicenter study of 61 cases of the Réseau d'Expertise Français des Cancers ORL Rares.
Aude VillepeletMarine LefèvreBenjamin VerillaudFrançois JanotRenaud GarrelSébastien VergezChloé BertolusOlivier MalardLudovic de GaboryOlivier MauvaisBertrand Baujatnull nullPublished in: Head & neck (2018)
Salivary duct carcinoma prognosis is poor and is correlated with tumor stage and lymph node classification. Androgen receptor and HER2/neu should be tested as they offer the possibility of targeted therapies.